{"id":"all-high-risk","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T03:20:54.587Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123513,"model":"claude-sonnet-4-5-20250929"},"competitors":[{"name":"blinatumomab","brand":"Blincyto","company":"Amgen","rationale":"BiTE therapy for relapsed/refractory ALL"},{"name":"inotuzumab ozogamicin","brand":"Besponsa","company":"Pfizer","rationale":"ADC for relapsed/refractory ALL"},{"name":"tisagenlecleucel","brand":"Kymriah","company":"Novartis","rationale":"CAR-T therapy for relapsed/refractory B-cell ALL"}],"description":"ALL, High risk is an investigational therapy in Phase 2 development by Jae Wook Lee for the treatment of high-risk acute lymphoblastic leukemia. Limited public information is available regarding its molecular target, mechanism of action, or specific drug class at this stage of clinical development.","indications":{"approved":[{"status":"investigational","condition":"Acute lymphoblastic leukemia (high-risk)","patientPopulation":"High-risk patients"}]},"trialDetails":[{"nctId":"NCT06735599","phase":"NA","title":"Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure","status":"RECRUITING","sponsor":"Georgia State University","startDate":"2024-09-17","conditions":"Hypertension (Without Type 2 Diabetes Mellitus), High Blood Pressure, Male","enrollment":40},{"nctId":"NCT06868914","phase":"PHASE1","title":"Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)","status":"NOT_YET_RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2026-04-01","conditions":"Healthy Volunteers","enrollment":35},{"nctId":"NCT03654105","phase":"PHASE2","title":"Screening and Multiple Intervention on Lung Epidemics","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2019-07-23","conditions":"Inflammation, Smoking Cessation, Diet Modification","enrollment":2000},{"nctId":"NCT06857929","phase":"NA","title":"\"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition\"","status":"RECRUITING","sponsor":"IMDEA Food","startDate":"2026-03-01","conditions":"Metabolic Syndrome, Obesity Prevention, Obesity and Overweight","enrollment":106},{"nctId":"NCT04929028","phase":"PHASE2","title":"Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-08-09","conditions":"AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma","enrollment":40},{"nctId":"NCT07498556","phase":"NA","title":"Immediate Restoration of a New Implant With High Primary Stability","status":"NOT_YET_RECRUITING","sponsor":"Universidade do Porto","startDate":"2026-03-01","conditions":"Dental Implants, Immediate Dental Implant Loading","enrollment":50},{"nctId":"NCT06371729","phase":"NA","title":"DEEP Substrate Mapping Versus Activation Mapping for VT","status":"RECRUITING","sponsor":"IRCCS Ospedale San Raffaele","startDate":"2024-06-13","conditions":"Ventricular Tachycardia","enrollment":222},{"nctId":"NCT07161011","phase":"PHASE2","title":"Phase 2b Controlled Study of Dosing Techniques - Part B","status":"COMPLETED","sponsor":"IVIEW Therapeutics Inc.","startDate":"2025-09-08","conditions":"Dry Eye","enrollment":15},{"nctId":"NCT07496086","phase":"NA","title":"External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative Pain in Laparoscopic Radical Gastrectomy","status":"RECRUITING","sponsor":"General Hospital of Ningxia Medical University","startDate":"2026-03-20","conditions":"Postoperative Pain","enrollment":100},{"nctId":"NCT06985056","phase":"NA","title":"Reducing Symptom Burden Through Physical Exercise in Melanoma Patients","status":"RECRUITING","sponsor":"Universität Duisburg-Essen","startDate":"2025-08-18","conditions":"Malignant Melanoma","enrollment":104},{"nctId":"NCT02579967","phase":"PHASE2","title":"Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-11-19","conditions":"Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases","enrollment":354},{"nctId":"NCT06417853","phase":"PHASE1","title":"Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)","status":"COMPLETED","sponsor":"Vaxxas Pty Ltd","startDate":"2024-07-31","conditions":"H7N9 Influenza","enrollment":267},{"nctId":"NCT07492381","phase":"NA","title":"A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer","status":"NOT_YET_RECRUITING","sponsor":"ALPFA Medical","startDate":"2026-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT07408375","phase":"NA","title":"Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2026-03-13","conditions":"Solid Tumor (Excluding CNS)","enrollment":560},{"nctId":"NCT03559283","phase":"NA","title":"fNIRS in the Evaluation of Cognitive-motor Interference in Post-stroke Patients","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2018-11-26","conditions":"D020521","enrollment":11},{"nctId":"NCT07067151","phase":"","title":"Using Smartwatches to Monitor Smoking in Real-life Situations","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute on Minority Health and Health Disparities (NIMHD)","startDate":"2026-04-01","conditions":"Smoking","enrollment":30},{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT07494435","phase":"PHASE2","title":"Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC","status":"NOT_YET_RECRUITING","sponsor":"Zhejiang Haichang Biotech Co., Ltd.","startDate":"2026-06-01","conditions":"Hepato Cellular Carcinoma (HCC), Renal Cell Cancer","enrollment":230},{"nctId":"NCT07498647","phase":"PHASE2","title":"Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia","status":"NOT_YET_RECRUITING","sponsor":"BioRay Pharmaceutical Co., Ltd.","startDate":"2026-04-01","conditions":"Gout and Hyperuricemia","enrollment":160},{"nctId":"NCT07496190","phase":"PHASE2","title":"Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-01","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":59},{"nctId":"NCT07495982","phase":"","title":"Correlation of Inflammatory Markers and Radiological Findings in Stable Bronchiectasis Patients With Exacerbation Phenotype","status":"RECRUITING","sponsor":"Sohag University","startDate":"2025-11-01","conditions":"Correlation of Inflammatory Markers and Radiological Findings in Stable Bronchiectasis Patients","enrollment":100},{"nctId":"NCT03914625","phase":"PHASE3","title":"A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-03","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome","enrollment":6720},{"nctId":"NCT07497113","phase":"NA","title":"The Effects of Commercially Available High Protein Drink on Amino Acid Bioavailability and Recovery From Muscle Fatiguing Exercise in 18-45-year-old Male and Female Participants.","status":"COMPLETED","sponsor":"Anglia Ruskin University","startDate":"2025-03-01","conditions":"Healthy Participants","enrollment":62},{"nctId":"NCT05593497","phase":"PHASE2","title":"A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-05-31","conditions":"High-Risk Prostate Cancer","enrollment":30},{"nctId":"NCT05941520","phase":"PHASE2","title":"Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-08-23","conditions":"Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ","enrollment":80},{"nctId":"NCT05718375","phase":"PHASE2","title":"Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria","status":"COMPLETED","sponsor":"Curacle Co., Ltd.","startDate":"2023-02-14","conditions":"Diabetic Nephropathies","enrollment":240},{"nctId":"NCT07324096","phase":"NA","title":"A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-03-24","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":100},{"nctId":"NCT06982222","phase":"PHASE1","title":"Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-03-31","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":24},{"nctId":"NCT00092222","phase":"PHASE2","title":"Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-10-28","conditions":"Lymphoproliferative Disorder, HHV-8, Malignancy","enrollment":75},{"nctId":"NCT05855824","phase":"NA","title":"Toddler Biomarker of Nutrition Study","status":"NOT_YET_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2026-06-01","conditions":"Pediatric Nutrition, Nutrition, Healthy","enrollment":150},{"nctId":"NCT03236428","phase":"PHASE2","title":"Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-11-24","conditions":"Monoclonal Gammopathy, Smoldering Multiple Myeloma","enrollment":42},{"nctId":"NCT03698019","phase":"PHASE2","title":"A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-02-15","conditions":"Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8","enrollment":313},{"nctId":"NCT06169215","phase":"PHASE2","title":"Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-07-23","conditions":"Multiple Myeloma","enrollment":70},{"nctId":"NCT06869447","phase":"NA","title":"New York Better Breathing Study","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2026-04-15","conditions":"Localized Lung Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8","enrollment":100},{"nctId":"NCT01038778","phase":"PHASE1, PHASE2","title":"Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-10-29","conditions":"Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7","enrollment":47},{"nctId":"NCT07495254","phase":"NA","title":"Effectiveness of Combined Super Inductive System (SIS) Therapy With Therapeutic Exercise and Health Education in Lateral Elbow Tendinopathy","status":"NOT_YET_RECRUITING","sponsor":"University of Vic - Central University of Catalonia","startDate":"2026-03-30","conditions":"Lateral Epicondylitis (Tennis Elbow), Lateral Epicondylalgia, Lateral Elbow Tendinopathy","enrollment":224},{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":478},{"nctId":"NCT07222488","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-09","conditions":"Bladder Cancer, Urinary Bladder Neoplasms","enrollment":45},{"nctId":"NCT00071786","phase":"","title":"Family Study of Affective and Anxiety Spectrum Disorders","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2004-05-21","conditions":"Mood Disorders, Sleep Disorders, Migraine","enrollment":1944},{"nctId":"NCT07495631","phase":"NA","title":"Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Acute Lymphoblastic Leukemia, Adult","enrollment":80},{"nctId":"NCT03605550","phase":"PHASE1","title":"A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2018-08-01","conditions":"High Grade Glioma, Diffuse Intrinsic Pontine Glioma","enrollment":64},{"nctId":"NCT06050252","phase":"PHASE2","title":"Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before Surgery","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-07-10","conditions":"Resectable Intrahepatic Cholangiocarcinoma","enrollment":27},{"nctId":"NCT05691478","phase":"PHASE2, PHASE3","title":"A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-03-03","conditions":"High Grade Osteosarcoma, Localized Osteosarcoma, Metastatic Osteosarcoma","enrollment":1122},{"nctId":"NCT00001204","phase":"","title":"Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1992-01-07","conditions":"Homozygous Familial Hypercholesterolemic","enrollment":73},{"nctId":"NCT07494084","phase":"PHASE4","title":"Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance","status":"NOT_YET_RECRUITING","sponsor":"Washington State University","startDate":"2026-05-01","conditions":"Shift Work Schedule, Circadian Rhythm, Insulin Resistance","enrollment":24},{"nctId":"NCT07211828","phase":"NA","title":"EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives","status":"RECRUITING","sponsor":"Chi Kwan Fung","startDate":"2025-10-10","conditions":"Sedation and Analgesia, Cholangiopancreatography, Endoscopic Retrograde, Anesthesia, General","enrollment":20},{"nctId":"NCT06052267","phase":"PHASE3","title":"A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations","status":"RECRUITING","sponsor":"Teva Branded Pharmaceutical Products R&D LLC","startDate":"2023-08-30","conditions":"Asthma","enrollment":2700},{"nctId":"NCT07497178","phase":"NA","title":"MRgFUS for Childhood Epilepsy","status":"NOT_YET_RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2026-03-01","conditions":"Drug Resistant Epilepsy, Epilepsy","enrollment":20},{"nctId":"NCT06425965","phase":"NA","title":"Effect of Hybrid Simulation Method on Advanced Life Support Application of Nursing Students","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2024-12-01","conditions":"Advanced Life Support, Simulation Training, Nursing Education","enrollment":73},{"nctId":"NCT01841723","phase":"PHASE2","title":"Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2013-04-30","conditions":"Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Recurrent Hairy Cell Leukemia","enrollment":44},{"nctId":"NCT00980460","phase":"PHASE3","title":"Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-09-14","conditions":"PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma","enrollment":236},{"nctId":"NCT06888323","phase":"PHASE1","title":"Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-27","conditions":"Refractory Myelodysplastic Syndrome","enrollment":30},{"nctId":"NCT05859347","phase":"NA","title":"Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-05-15","conditions":"Cannabis Use Disorder","enrollment":46},{"nctId":"NCT07494149","phase":"NA","title":"Group-Based Exercise Intervention to Prevent Cognitive and Motor Decline","status":"RECRUITING","sponsor":"University of Bergamo","startDate":"2026-02-01","conditions":"Healthy, Older Adults","enrollment":158},{"nctId":"NCT06186869","phase":"NA","title":"Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLD","status":"RECRUITING","sponsor":"Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis","startDate":"2023-10-02","conditions":"Obesity, NAFLD","enrollment":90},{"nctId":"NCT03233711","phase":"PHASE3","title":"Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-07-05","conditions":"Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma","enrollment":344},{"nctId":"NCT02166463","phase":"PHASE3","title":"Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-03-19","conditions":"Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma","enrollment":600},{"nctId":"NCT04139616","phase":"","title":"Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR","status":"RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2020-02-25","conditions":"Conduction Disturbances, Transcatheter Aortic Valve Replacement, Permanent Pacemaker Implantation","enrollment":2000},{"nctId":"NCT07494357","phase":"NA","title":"Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke","status":"NOT_YET_RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2026-04-01","conditions":"Stroke, Cerebrovascular","enrollment":36},{"nctId":"NCT06745921","phase":"PHASE1","title":"Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-02-24","conditions":"West Nile Viral Infection","enrollment":30},{"nctId":"NCT06643598","phase":"NA","title":"Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2025-06-03","conditions":"Hypoxic Ischaemic Encephalopathy (HIE), Premature Birth, Cerebral Palsy","enrollment":225},{"nctId":"NCT07062016","phase":"","title":"Molecular and ctDNA Characterization of High-Risk Endometrial Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-10-01","conditions":"Endometrial Carcinoma, Endometrial High Grade Endometrioid Adenocarcinoma, Stage II Endometrial Cancer","enrollment":100},{"nctId":"NCT03969004","phase":"PHASE3","title":"Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2019-06-04","conditions":"Cutaneous Squamous Cell Carcinoma","enrollment":415},{"nctId":"NCT06744504","phase":"PHASE3","title":"Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-01-10","conditions":"AML, RUNX1-RUNX1T1 Fusion Protein Expression","enrollment":300},{"nctId":"NCT06858579","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)","status":"RECRUITING","sponsor":"Dianthus Therapeutics","startDate":"2025-02-10","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":480},{"nctId":"NCT07276360","phase":"PHASE2","title":"Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda","status":"RECRUITING","sponsor":"Uganda Cancer Institute","startDate":"2026-03-11","conditions":"Cervical Cancer, Cervix Cancer, Cervical Adenocarcinoma","enrollment":278},{"nctId":"NCT07494903","phase":"NA","title":"Effects of Vibrational Therapy on Pelvic Floor Muscle Strength and Tone in Healthy Women","status":"NOT_YET_RECRUITING","sponsor":"Universidad Europea de Madrid","startDate":"2026-06-01","conditions":"Healhty","enrollment":60},{"nctId":"NCT06770582","phase":"PHASE2","title":"Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-03","conditions":"Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v8","enrollment":160},{"nctId":"NCT02830724","phase":"PHASE1, PHASE2","title":"Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-04-06","conditions":"Pancreatic Cancer, Renal Cell Cancer, Breast Cancer","enrollment":124},{"nctId":"NCT02506153","phase":"PHASE3","title":"Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-11-10","conditions":"Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma","enrollment":1301},{"nctId":"NCT05521776","phase":"NA","title":"Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-06","conditions":"Preeclampsia (PE)","enrollment":14500},{"nctId":"NCT03844061","phase":"PHASE2","title":"Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-29","conditions":"Systemic Sclerosis","enrollment":30},{"nctId":"NCT07497230","phase":"NA","title":"Asymmetric High-Flow Nasal Cannula During Pulmonary Rehabilitation in COPD","status":"COMPLETED","sponsor":"Universidad de Santiago de Chile","startDate":"2025-05-02","conditions":"Pulmonary Disease, Chronic Obstructive (COPD), Dyspnea, Exercise Tolerance","enrollment":30},{"nctId":"NCT06880003","phase":"NA","title":"Cord Blood Preptin Levels in Infants","status":"COMPLETED","sponsor":"Konya City Hospital","startDate":"2025-03-10","conditions":"Newborn Morbidity, Newborn Complication","enrollment":72},{"nctId":"NCT07496931","phase":"","title":"Construction and Analysis of a Risk Prediction Model for Acute Myocardial Infarction Based on Spatiotemporal Heterogeneous Data","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-03-25","conditions":"Acute Myocardial Infarction (AMI)","enrollment":3000},{"nctId":"NCT05142735","phase":"NA","title":"Effects of NAC on Symptoms of CHR Patients","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-01-13","conditions":"Prodromal Schizophrenia","enrollment":90},{"nctId":"NCT04628767","phase":"PHASE2, PHASE3","title":"Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-11-12","conditions":"Renal Pelvis and Ureter Urothelial Carcinoma","enrollment":249},{"nctId":"NCT07496957","phase":"NA","title":"Preserflo MicroShunt Versus Trabeculectomy","status":"RECRUITING","sponsor":"Medical University of Bialystok","startDate":"2026-03-01","conditions":"GLAUCOMA 1, OPEN ANGLE, D (Disorder)","enrollment":100},{"nctId":"NCT06060938","phase":"NA","title":"Personalized Breast Cancer Screening","status":"ACTIVE_NOT_RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2024-02-02","conditions":"Breast Cancer","enrollment":2200},{"nctId":"NCT06321198","phase":"NA","title":"A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2024-02-10","conditions":"Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)","enrollment":12},{"nctId":"NCT03297606","phase":"PHASE2","title":"Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2018-03-23","conditions":"Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors","enrollment":720},{"nctId":"NCT05826509","phase":"PHASE2","title":"SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Claudius Regaud","startDate":"2023-08-10","conditions":"Prostate Cancer","enrollment":240},{"nctId":"NCT07496411","phase":"NA","title":"Predictive Validity and Clinical Utility of an Ultrasound-based Quantitative Risk Score for Pressure Injury in Critically Ill Patients: A Two-Phase Sequential Study","status":"NOT_YET_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2026-03-20","conditions":"Pressure Injury","enrollment":390},{"nctId":"NCT04940468","phase":"NA","title":"High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2022-10-21","conditions":"Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Lymphoma","enrollment":5},{"nctId":"NCT04628026","phase":"PHASE3","title":"Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2","status":"RECRUITING","sponsor":"University of Ulm","startDate":"2022-09-13","conditions":"Acute Myeloid Leukemia","enrollment":650},{"nctId":"NCT07169617","phase":"PHASE2","title":"Testing the SurVaxM Vaccine for Lung Cancer Prevention","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-02-25","conditions":"Lung Carcinoma","enrollment":80},{"nctId":"NCT07012044","phase":"PHASE1","title":"A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-10-30","conditions":"Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":47},{"nctId":"NCT06492616","phase":"PHASE3","title":"A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence","status":"RECRUITING","sponsor":"Stemline Therapeutics, Inc.","startDate":"2024-09-27","conditions":"Breast Cancer","enrollment":4220},{"nctId":"NCT06652815","phase":"","title":"Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-12-01","conditions":"Persons With High Suicide Ideation or Attempts","enrollment":220},{"nctId":"NCT07495332","phase":"NA","title":"Siemens Biomarker Multi-modality","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-03","conditions":"Fatty Liver, Hepatic Steatosis","enrollment":45},{"nctId":"NCT07287670","phase":"PHASE2","title":"EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)","status":"NOT_YET_RECRUITING","sponsor":"Mediar Therapeutics","startDate":"2026-02","conditions":"Diffuse Cutaneous Systemic Sclerosis","enrollment":85},{"nctId":"NCT06980428","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-05-27","conditions":"Healthy Participants, Dyslipidemia","enrollment":136},{"nctId":"NCT03947905","phase":"NA","title":"Virtual and Physical Health Assessments and Treatment Plans","status":"WITHDRAWN","sponsor":"CAMC Health System","startDate":"2019-04-04","conditions":"Vascular Diseases","enrollment":""},{"nctId":"NCT06838676","phase":"PHASE2","title":"ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas","status":"RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2025-07-10","conditions":"Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG, Refractory DIPG","enrollment":60},{"nctId":"NCT04307576","phase":"PHASE3","title":"A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia","status":"RECRUITING","sponsor":"Mats Heyman","startDate":"2020-07-13","conditions":"Leukemia, Acute Lymphoblastic","enrollment":6430},{"nctId":"NCT07133633","phase":"PHASE2","title":"A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-09-26","conditions":"Radiographic Axial Spondyloarthritis","enrollment":315},{"nctId":"NCT05145647","phase":"NA","title":"To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-03-30","conditions":"Esophageal Cancer","enrollment":18},{"nctId":"NCT07219719","phase":"PHASE1","title":"Temporal Interference for Thalamocortical Activity and Network Modulation","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2025-12-01","conditions":"Healthy Participants","enrollment":30},{"nctId":"NCT02997228","phase":"PHASE3","title":"Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-19","conditions":"Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7","enrollment":120},{"nctId":"NCT07498790","phase":"NA","title":"Equal-Volume Pilates Frequency in Women With Overweight and Obesity","status":"COMPLETED","sponsor":"Pamukkale University","startDate":"2023-09-11","conditions":"Overweight and Obesity","enrollment":51}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":907,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ALL, High risk","genericName":"ALL, High risk","companyName":"Jae Wook Lee","companyId":"jae-wook-lee","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ALL (Sirolimus) is a small molecule used in research to study its effects on adolescent athletic performance, muscle strength development, and injury prevention in sports. It has been studied in combination with back squats and blood flow restriction exercises in healthy adolescent basketball athletes.","enrichmentLevel":2,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}